Literature DB >> 16823472

Insulin resistance and pancreatic beta cell failure.

Masato Kasuga1.   

Abstract

It is now well accepted that diabetes mellitus is one of the main threats to human health in the twenty-first century. The total number of people with diabetes worldwide was estimated at between 151 million and 171 million in 2000 and is projected to increase to 221 million in 2010 and to 366 million in 2030. Needless to say, the increase in the number of people with diabetes will be accompanied by an increase in the number of those with diabetic complications such as nephropathy, retinopathy, neuropathy, and atherosclerosis. The global mortality attributable to diabetes in the year 2000 was estimated at 2.9 million deaths, a number that will also increase. Given that type 2 diabetes accounts for more than 90% of cases of diabetes worldwide, it is important that we understand the pathogenesis of this condition and develop new approaches to its prevention and treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16823472      PMCID: PMC1483164          DOI: 10.1172/JCI29189

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

Authors:  R N Kulkarni; J C Brüning; J N Winnay; C Postic; M A Magnuson; C R Kahn
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

2.  Transgenic rescue of insulin receptor-deficient mice.

Authors:  Haruka Okamoto; Jun Nakae; Tadahiro Kitamura; Byung-Chul Park; Ioannis Dragatsis; Domenico Accili
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

3.  Hypothalamic insulin signaling is required for inhibition of glucose production.

Authors:  Silvana Obici; Bei B Zhang; George Karkanias; Luciano Rossetti
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

4.  Disruption of IRS-2 causes type 2 diabetes in mice.

Authors:  D J Withers; J S Gutierrez; H Towery; D J Burks; J M Ren; S Previs; Y Zhang; D Bernal; S Pons; G I Shulman; S Bonner-Weir; M F White
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

5.  Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes.

Authors:  Umut Ozcan; Qiong Cao; Erkan Yilmaz; Ann-Hwee Lee; Neal N Iwakoshi; Esra Ozdelen; Gürol Tuncman; Cem Görgün; Laurie H Glimcher; Gökhan S Hotamisligil
Journal:  Science       Date:  2004-10-15       Impact factor: 47.728

6.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

7.  Why does diabetes increase atherosclerosis? I don't know!

Authors:  Ira J Goldberg
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.

Authors:  Hiroshi Inoue; Wataru Ogawa; Michitaka Ozaki; Sanae Haga; Michihiro Matsumoto; Kensuke Furukawa; Naoko Hashimoto; Yoshiaki Kido; Toshiyuki Mori; Hiroshi Sakaue; Kiyoshi Teshigawara; Shiyu Jin; Haruhisa Iguchi; Ryuji Hiramatsu; Derek LeRoith; Kiyoshi Takeda; Shizuo Akira; Masato Kasuga
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

Review 9.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more
  115 in total

1.  High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Endocrine       Date:  2018-04-12       Impact factor: 3.633

2.  Mysteries of type 2 diabetes: the Indian Elephant meets the Chinese Dragon.

Authors:  E C Rhodes; U P Gujral; K M Narayan
Journal:  Eur J Clin Nutr       Date:  2017-06-14       Impact factor: 4.016

3.  The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study.

Authors:  Unjali P Gujral; K M Venkat Narayan; Steven E Kahn; Alka M Kanaya
Journal:  J Diabetes Complications       Date:  2013-10-11       Impact factor: 2.852

4.  Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism.

Authors:  F Frigerio; T Brun; C Bartley; A Usardi; D Bosco; K Ravnskjaer; S Mandrup; P Maechler
Journal:  Diabetologia       Date:  2009-11-12       Impact factor: 10.122

5.  Ablation of C/EBPbeta alleviates ER stress and pancreatic beta cell failure through the GRP78 chaperone in mice.

Authors:  Tomokazu Matsuda; Yoshiaki Kido; Shun-ichiro Asahara; Tsuneyasu Kaisho; Takashi Tanaka; Naoko Hashimoto; Yutaka Shigeyama; Akihiko Takeda; Tae Inoue; Yuki Shibutani; Maki Koyanagi; Tetsuya Hosooka; Michihiro Matsumoto; Hiroshi Inoue; Tohru Uchida; Masato Koike; Yasuo Uchiyama; Shizuo Akira; Masato Kasuga
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 6.  Growth factor control of pancreatic islet regeneration and function.

Authors:  Anke Assmann; Charlotte Hinault; Rohit N Kulkarni
Journal:  Pediatr Diabetes       Date:  2008-09-19       Impact factor: 4.866

7.  Ranking candidate genes in rat models of type 2 diabetes.

Authors:  Lars Andersson; Greta Petersen; Fredrik Ståhl
Journal:  Theor Biol Med Model       Date:  2009-07-03       Impact factor: 2.432

Review 8.  Successful weight loss surgery improves eating control and energy metabolism: a review of the evidence.

Authors:  Dave H Schweitzer; Emile F Dubois; Niki van den Doel-Tanis; Hok I Oei
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

9.  Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.

Authors:  Anne Flint; Khalil Nazzal; Pawel Jagielski; Charlotte Hindsberger; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

10.  Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger.

Authors:  M Novelli; B Bonamassa; M Masini; N Funel; D Canistro; V De Tata; M Martano; A Soleti; D Campani; M Paolini; P Masiello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-29       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.